In children with attention-deficit hyperactivity disorder who have been taking methylphenidate for at least 1 year, is there any evidence of harmful effects?

Evidence-Based Healthcare and Public Health

Volumn 9, Issue 1, 2005, Pages 10-15

  Hazell, Philip L ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMFEBUTAMONE; ATOMOXETINE; BUSPIRONE; CLONIDINE; DESIPRAMINE; GUANFACINE; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; PLACEBO; PSYCHOSTIMULANT AGENT; VENLAFAXINE;

ABDOMINAL PAIN; ALCOHOL ABUSE; ANOREXIA; APPETITE DISORDER; ATTENTION DEFICIT DISORDER; BODY WEIGHT DISORDER; CARDIOVASCULAR EFFECT; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG EFFICACY; EMOTIONAL DISORDER; EVIDENCE BASED MEDICINE; GROWTH DISORDER; HEADACHE; HUMAN; LONG TERM CARE; MOOD DISORDER; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER; SUBSTANCE ABUSE; SYMPTOMATOLOGY; TIC;

EID: 13944281462     PISSN: 17442249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehbc.2004.11.015     Document Type: Note

References (29)

1. R.A. Barkley Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder J Clin Psychiatry 63 Suppl 12 2002 10-15
2. M. Fischer R.A. Barkley L. Smallish K. Fletcher Young adult follow-up of hyperactive children: Self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD J Abnorm Child Psychol 30 2002 463-475
3. S. Mannuzza R.G. Klein A. Bessler P. Malloy M. LaPadula Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status Arch Gen Psychiatry 50 1993 565-576
4. S. Mannuzza R.G. Klein A. Bessler P. Malloy M.E. Hynes Educational and occupational outcome of hyperactive boys grown up J Am Acad Child Adolesc Psychiatry 36 1997 1222-1227
5. S. Mannuzza R.G. Klein Long-term prognosis in attention-deficit/hyperactivity disorder Child Adolesc Psychiatr Clin N Am 9 2000 711-726
6. G. Weiss L. Hechtman T. Milroy T. Perlman Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children J Am Acad Child Adolesc Psychiatry 24 1985 211-220
7. B.W. Graetz M.G. Sawyer P.L. Hazell F. Arney P. Baghurst Validity of DSM-IVADHD subtypes in a nationally representative sample of Australian children and adolescents J Am Acad Child Adolesc Psychiatry 40 2001 1410-1417
8. P.S. Jensen et al. Are stimulants overprescribed? Treatment of ADHD in four US communities J Am Acad Child Adolesc Psychiatry 38 1999 797-804
9. M.G. Sawyer J.M. Rey B.W. Graetz J.J. Clark P.A. Baghurst Use of medication by young people with attention-deficit/hyperactivity disorder Med J Aust 177 2002 21-25
10. American Academy of Child and Adolescent Psychiatry Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 36 1997 85S-121S
11. M. Olfson S.C. Marcus M.M. Weissman P.S. Jensen National trends in the use of psychotropic medications by children J Am Acad Child Adolesc Psychiatry 41 2002 514-521
12. Hazell P. A review of the newer compounds available in Australia for the treatment of attention-deficit/hyperactivity disorder. Australasian Psychiatry (in press).
13. J. Elia B.G. Borcherding J.L. Rapoport C.S. Keysor Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders? Psychiatry Res 36 1991 141-155
14. Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R. Treatment of attention-deficit/hyperactivity disorder. Evidence Report: Technology Assessment (Summary) 2001; i-viii.
15. The MTA Collaborative Group A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder Arch Gen Psychiatry 56 1998 1073-1086
16. D.J. Safer J.M. Zito Pharmacoepidemiology of methylphenidate and other stimulants for the treatment of attention deficit hyperactivity disorder In: L. Greenhill B. Osman (Eds.) Ritalin Theory and Practice 2000 Mary Ann Liebert Larchmant NY 7-26
17. B. McNutt J.E. Ballard R. Boileau The effects of long-term stimulant medication on growth and body composition of hyperactive children Psychopharmacol Bull 12 1976 13-15
18. B.A. McNutt R.A. Boileau M.N. Cohen The effects of long-term stimulant medication on the growth and body composition of hyperactive children Psychopharmacol Bull 13 1977 36-38
19. D. Safer R. Allen E. Barr Depression of growth in hyperactive children on stimulant drugs N Engl J Med 287 1972 217-220
20. D.J. Safer R.P. Allen Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children Pediatrics 51 1973 660-667
21. T. Spencer J. Biederman V. Wright M. Danon Growth deficits in children treated with desipramine: A controlled study J Am Acad Child Adolesc Psychiatry 31 1992 235-243
22. M.C. Lisska S.A. Rivkees Daily methylphenidate use slows the growth of children: A community based study J Pediatr Endocrinol Metab 16 2003 711-718
23. T.J. Spencer et al. Growth deficits in ADHD children revisited: Evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 35 1996 1460-1469
24. S.F. Law R.J. Schachar Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 38 1999 944-951
25. S.V. Faraone T. Wilens Does stimulant treatment lead to substance use disorders? J Clin Psychiatry 64 Suppl 11 2003 9-13
26. L. Hechtman B. Greenfield Long-term use of stimulants in children with attention deficit hyperactivity disorder: Safety, efficacy, and long-term outcome Pediatric Drugs 5 2003 787-794
27. A. Charach A. Ickowicz R. Schachar Stimulant treatment over five years: adherence, effectiveness, and adverse effects J Am Acad Child Adolesc Psychiatry 43 2004 559-567
28. Greenhill LL, Vitiello B, Abikoof H, et al. Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000. J Am Acad Child Adolesc Psychiatry 2003; 42: 651-655.
29. Hazell RL, Lewing TJ, McDowell MJ, WJM. Factors associated with medium-term response to psychostimulant medication. J. Paediatr. Child Health 1999; 35: 264-269.